1 Min Read
Jan 10 (Reuters) - Kite Pharma Inc
* says it establishes joint venture with Fosun Pharma in China to develop and commercialize autologous t-cell therapies to treat cancer
Source text for Eikon:
Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.